Geneva, Oct. 8 -- International Clinical Trials Registry received information related to the study (ISRCTN16011638) titled 'A study of a traditional Chinese herbal formula combined with standard medication for treating a specific type of rheumatoid arthritis' on Sept. 24.
Study Type: Interventional
Study Design:
Single-center interventional double-blinded randomized controlled trial (Treatment, Safety, Efficacy)
Primary Sponsor: Beijing Municipal Health Commission
Condition:
Rheumatoid arthritis with cold dampness obstruction and depression
Musculoskeletal Diseases
Intervention:
Intervention group: Participants will receive Wenyang Jieyu granules (1 dose daily, dissolved in water and taken in two divided doses) in combination wit...